Cite
Subcutaneous recombinant granulocyte-macrophage colony-stimulating factor used as a single agent and in an alternating regimen with azidothymidine in leukopenic patients with severe human immunodeficiency virus infection
MLA
J M, Pluda, et al. “Subcutaneous Recombinant Granulocyte-Macrophage Colony-Stimulating Factor Used as a Single Agent and in an Alternating Regimen with Azidothymidine in Leukopenic Patients with Severe Human Immunodeficiency Virus Infection.” Blood, vol. 76, no. 3, Aug. 1990. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........031b7e0019b44d290c0622d67529b32e&authtype=sso&custid=ns315887.
APA
J M, P., R, Y., P D, S., N, M., L E, S., D, O., M, M., S M, W., C E, M., & S, B. (1990). Subcutaneous recombinant granulocyte-macrophage colony-stimulating factor used as a single agent and in an alternating regimen with azidothymidine in leukopenic patients with severe human immunodeficiency virus infection. Blood, 76(3).
Chicago
J M, Pluda, Yarchoan R, Smith P D, McAtee N, Shay L E, Oette D, Maha M, Wahl S M, Myers C E, and Broder S. 1990. “Subcutaneous Recombinant Granulocyte-Macrophage Colony-Stimulating Factor Used as a Single Agent and in an Alternating Regimen with Azidothymidine in Leukopenic Patients with Severe Human Immunodeficiency Virus Infection.” Blood 76 (3). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........031b7e0019b44d290c0622d67529b32e&authtype=sso&custid=ns315887.